 |
DISTRICT COURT WAS NOT BOUND BY PREVIOUS CLAIM CONSTRUCTION IN APPLYING BECTON * *
Regeneron Pharms, Inc. v. Mylan Pharms Inc., 24-2351
|
March 14, 2025 |
IPO Federal Circuit Summaries |
|
REISSUED PATENTS ENTITLED TO PTE BASED ON ORIGINAL PATENT’S ISSUE DATE* *
Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc., 23-225
|
March 13, 2025 |
IPO Federal Circuit Summaries |
|
JEPSON CLAIM PREAMBLE REQUIRES A WRITTEN DESCRIPTION *
In re Xencor, Inc., 24-1870
|
March 13, 2025 |
IPO Federal Circuit Summaries |
|
MARKS MUST BE CONSIDERED GENERIC AT TIME OF REGISTRATION TO BE DENIED PROTECTION * *
Bullshine Distillery LLC v. Sazerac Brands, LLC, 23-1682, 23-1900
|
March 12, 2025 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT CONCLUSION FAILED TO FOLLOW FROM THE PREMISE DESCRIBING CLAIM LANGUAGE* *
Sierra Wireless, ULC v. Sisvel S.P.A., 23-1059, 23-1085, 23-1089, 23-1125
|
March 10, 2025 |
IPO Federal Circuit Summaries |
|
NO SPECIFIC THREAT OF INFRINGEMENT OR IDENTIFICATION OF INFRINGING PRODUCT NEEDED TO SHOW INJURY-IN-FACT*
CQV Co., Ltd. v. Merck Patent GMBH, 23-1027
|
March 10, 2025 |
IPO Federal Circuit Summaries |
|
ALIVECOR FORFEITED DISCOVERY ARGUMENT ON APPEAL*
Alivecor, Inc. v. Apple, Inc., 23-1512, 23-1513, 23-1514
|
March 07, 2025 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT CLAIM CONSTRUCTION IMPROPERLY IMPORTED LIMITATIONS INTO CLAIMS *
IQRIS Techs. LLC v. Point Blank Enters., Inc., 23-2062
|
March 07, 2025 |
IPO Federal Circuit Summaries |
|
SPECIFIC PROBLEMS UNKNOWN IN THE ART AT THE TIME OF THE INVENTION DID NOT NECESSARILY RENDER CLAIMED SOLUTION NON-OBVIOUS *
ImmunoGen, Inc. v. Stewart, 23-1762
|
March 06, 2025 |
IPO Federal Circuit Summaries |
|
USPTO PROPERLY DECLINED REQUEST FOR DIRECTOR REVIEW UNDER FRCP 60(B)(6) * *
Odyssey Logistics & Tech. Corp. v. Stewart, 23-2077
|
March 06, 2025 |
IPO Federal Circuit Summaries |
|
SECTION 337(A)(3)(B) DOMESTIC-INDUSTRY REQUIREMENT DOES NOT REQUIRE DOMESTIC MANUFACTURING ACTIVITY * * *
Lashify, Inc. v. Int’l Trade Comm., 23-1245
|
March 05, 2025 |
IPO Federal Circuit Summaries |
|
PRODUCT-BY-PROCESS CLAIMS ARE NOT AUTOMATICALLY INHERENTLY ANTICIPATED * *
Restem, LLC v. Jadi Cell, LLC, 23-2054
|
March 04, 2025 |
IPO Federal Circuit Summaries |
|
CLAIMS NOT DIRECTED TOWARD INELIGIBLE ABSTRACT IDEA DUE TO CONCRETE RELATIONSHIP BETWEEN RECITED PROPERTIES AND CLAIMED STRUCTURAL DETAILS* *
U.S. Synthetic Corp. v. Int’l Trade Comm., 23-1217
|
February 13, 2025 |
IPO Federal Circuit Summaries |
|
INFRINGEMENT CAUSE OF ACTION CANNOT BE PRECLUDED BY IPR DECISION FINDING IMMATERIALLY DIFFERENT CLAIMS UNPATENTABLE* *
Kroy IP Holdings LLC v. Groupon, Inc., 23-1359
|
February 10, 2025 |
IPO Federal Circuit Summaries |
|
PATENT INFRINGEMENT CASE REASSIGNED ON REMAND * *
Trudell Med. Int’l Inc. v. D R Burton Healthcare, LLC, 23-1777, 23-1779
|
February 07, 2025 |
IPO Federal Circuit Summaries |
|
SMALL MARKET SEGMENTS CAN BE SIGNIFICANT INVESTMENT UNDER DOMESTIC INDUSTRY REQUIREMENT * *
Wuhan Healthgen Biotech. Corp. v. Int’l Trade Comm., 23-1389
|
February 07, 2025 |
IPO Federal Circuit Summaries |
|
USPTO ERRONEOUSLY CONSTRUED ELEMENTS CLAIMED BY INTEGRATED CIRCUIT PATENT *
HD Silicon Solutions LLC v. Microchip Tech. Inc., 23-1397
|
February 06, 2025 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT DECLINES TO ADDRESS VALIDITY OF REVERSE DOCTRINE OF EQUIVALENTS*
Steuben Foods, Inc. v. Shibuya Hoppman Corp., 23-1790
|
January 24, 2025 |
IPO Federal Circuit Summaries |
|
PUBLISHED PATENT APPLICATION WAS A PRIOR ART PRINTED PUBLICATION AT THE TIME OF FILING * *
Lynk Labs, Inc. v. Samsung Electronics Co., 23-2346
|
January 14, 2025 |
IPO Federal Circuit Summaries |
|
STATE LAW CONVERSION CLAIM OVER METHOD OF BITCOIN MINING PREEMPTED BY FEDERAL PATENT LAW *
BearBox LLC v. Lancium LLC, 23-1922
|
January 13, 2025 |
IPO Federal Circuit Summaries |
|
**DISTRICT COURT ERRED IN FINDING HEART MEDICATION THERAPY INVALID FOR LACK OF WRITTEN DESCRIPTION * *
Novartis Pharms. Corp. v. Torrent Pharma Inc., 23-2218, 23-2220, 23-221
|
January 10, 2025 |
IPO Federal Circuit Summaries |
|
COPYRIGHT INFRINGEMENT DAMAGES CANNOT BE CALCULATED ON A PER-COPY BASIS *
Bitmanagement Software GmBH v. U.S., 23-1506
|
January 07, 2025 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT CORRECTLY APPLIED TRADEMARK FUNCTIONALITY DOCTRINE TO DESIGN FEATURES OF EXPIRED PATENT* *
CeramTec GMBH v. Coorstek Bioceramics LLC, 23-1502
|
January 03, 2025 |
IPO Federal Circuit Summaries |
|
USPTO DETERMINATION OF NON-OBVIOUSNESS WAS NOT SUPPORTED BY SUBSTANTIAL EVIDENCE* *
Honeywell Int’l Inc. v. 3G Licensing, S.A., 23-1354, 23-1384, 23-1407
|
January 02, 2025 |
IPO Federal Circuit Summaries |
|
DEVICE PATENTS DO NOT MEET ORANGE BOOK LISTING REQUIREMENTS* *
Teva Branded Pharm. Prods. R&D, Inc. v. Amneal Pharms of N.Y. LLC, 24-1936
|
December 20, 2024 |
IPO Federal Circuit Summaries |
|
CONTRACTUAL OBLIGATION NOT AMOUNTING TO DIRECTION OR CONTROL OF THIRD-PARTY DID NOT CREATE VICARIOUS LIABILITY* *
CloudofChange, LLC, v. NCR Corp., 23-1111
|
December 18, 2024 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT FAILED TO DETERMINE MOTIVATION TO COMBINE*
Palo Alto Networks, Inc. v. Centripetal Networks LLC, 23-1636
|
December 16, 2024 |
IPO Federal Circuit Summaries |
|
EXPRESS RESERVATION OF ACCEPTANCE DOES NOT PRECLUDE FORMATION OF COMMERCIAL CONTRACT OF SALE*
|
December 10, 2024 |
IPO Federal Circuit Summaries |
|
IPR PROCEEDING DOES NOT PRECLUDE ISSUE OF CLAIM CONSTRUCTION AT TRIAL* *
DDR Holdings, LLC v. Priceline.com LLC, 23-1176, 23-1177
|
December 09, 2024 |
IPO Federal Circuit Summaries |
|
IMPOSING FEES UNDER 35 U.S.C. § 285 DOES NOT PRECLUDE SANCTIONS UNDER COURT’S INHERENT POWERS * *
https://cafc.uscourts.gov/opinions-orders/23-1665.OPINION.12-6-2024_2431484.pdf
|
December 06, 2024 |
IPO Federal Circuit Summaries |
|
EVIDENCE INSUFFICIENT TO OVERCOME SUMMARY JUDGMENT OF NONINFRINGEMENT* *
Mirror Worlds Techs., LLC v. Meta Platforms, Inc., 22-1600, 22-1709
|
December 04, 2024 |
IPO Federal Circuit Summaries |
|
REASONABLE EXPECTATION OF SUCCESS ANALYSIS NOT REQUIRED WHEN CLAIM RECITES INHERENT PROPERTY OF OTHERWISE OBVIOUS COMBINATION* *
Cytiva Bioprocess R&D AB v. JSR Corp., 23-2074, 23-2075, 23-2191, 23-2193, 23-2194, 23-2239, 23-2252, 23-2253, 23-2255
|
December 04, 2024 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT DENIES MOTION TO DISMISS APPEAL FILED AFTER OPINION ISSUED*
Cisco Sys., Inc. v. K.Mizra LLC, 22-2290, 23-2283
|
November 19, 2024 |
IPO Federal Circuit Summaries |
|
EXPERT TESTIMONY WAS NOT SUFFICIENT FOR INFRINGEMENT UNDER DOCTRINE OF EQUIVALENTS* *
Nexstep, Inc. v. Comcast Cable Commc’ns, LLC, 22-1815, 22-2005, 22-2113
|
October 24, 2024 |
IPO Federal Circuit Summaries |
|
ETSI MEMBERS MUST ADHERE TO GOOD FAITH NEGOTIATING OBLIGATIONS TO ENJOIN FOREIGN USE OF SEPS*
Telefonaktiebolaget LM Ericsson v. Lenovo (U.S.), Inc., 24-1515
|
October 24, 2024 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT MAY ENGAGE IN CLAIM CONSTRUCTION ON MOTION TO DISMISS* *
UTTO Inc. v. Metrotech Corp., 23-1435
|
October 18, 2024 |
IPO Federal Circuit Summaries |
|
CONCLUSORY PATENT INFRINGEMENT CLAIMS MUST BE REVIEWED DE NOVO* *
AlexSam, Inc. v. Aetna, Inc., 22-2036
|
October 08, 2024 |
IPO Federal Circuit Summaries |
|
PRODUCT FALSELY ADVERTISED AS PATENTED GAVE RISE TO UNFAIR COMPETITION CLAIM* *
Crocs, Inc. v. Effervescent, Inc., 22-2160
|
October 03, 2024 |
IPO Federal Circuit Summaries |
|
INFRINGING CONFIGURATION NOT READILY AVAILABLE TO CUSTOMERS DID NOT MEET CAPABILITY STANDARD*
Provisur Techs., Inc. v. Weber, Inc., 23-1438
|
October 02, 2024 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT GRANTS REHEARING EN BANC ON EXPERT DAMAGES TESTIMONY*
EcoFactor, Inc. v. Google LLC, 23-1101
|
September 25, 2024 |
IPO Federal Circuit Summaries |
